Antibody pair for detecting dermatophagoides farinae and main allergen Der f 1 of dermatophagoides farinae and application of antibody pair
By using antibodies DF1.10 and DF1.19 prepared by hybridoma cells, the problem of cross-reaction of anti-Der f1 monoclonal antibodies with Der p1 was solved, and specific and high sensitivity detection of Der f1 was achieved, ensuring that Accuracy and specificity of the test.
Patent Information
- Application Number
- CN202411119324.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-29
AI Technical Summary
The existing anti-Derf1 monoclonal antibody has a cross-reaction with Derp1, which affects the detection specificity and makes it difficult to specifically detect the main allergen of Derf1 of dust mites.
Antibodies DF1.10 and DF1.19 were prepared using hybridoma cells CGMCC No. 45854 and CGMCC No. 45855, and were specifically detected by ELISA and immunochromatography detection reagents, using these antibodies to recognize and bind to the Derf1 protein.
The specificity and high sensitivity detection of Der f 1 are achieved, ensuring the accuracy and specificity of the detection, and avoiding cross-reaction with Der p 1.
Smart Images

Figure BDA0004994566110000091 
Figure BDA0004994566110000121 
Figure BDA0004994566110000122
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology, and in particular relates to an antibody pair for detecting dust mites and their main allergen Der f1 and an application thereof. Background Art
[0002] Dermatophagoides farinae is the main allergen that causes existing allergic diseases. Among them, the main allergen Der f 1 (class I allergen of dust mite) is present in the intestinal contents and midgut tissues of mites. It is a cysteine protease with a molecular weight of 25000KDa and belongs to the papain family. Currently, about 66.7% of the sera of patients with dust mite allergy react with Der f 1. It may induce allergic reactions by cutting off the IL-2 receptor on the surface of peripheral blood T cells through cysteine protease activity, inhibiting the proliferation of T cells and the secretion of IFN-γ, or by cutting off CD23 on the surface of B cells, eliminating the inhibitory signal of IgE synthesis, stimulating the production pathway of IgE, etc.
[0003] At present, standardized dust mite allergens are often used in clinical practice to specifically diagnose dust mite allergy and perform desensitization treatment. As the main allergen of dust mites, the content of Der f 1 in desensitization drugs has become an important indicator for evaluating the effectiveness of drugs. Therefore, the preparation of a monoclonal antibody that can detect Der f 1 antigen is of great significance for the quality control of allergen extracts and the standardization and comparison of allergen products.
[0004] Several anti-Der f 1 monoclonal antibodies have been marketed, but they all have varying degrees of cross-reaction with Der p 1, the main allergen of house dust mites, which affects the specificity of detection. Der p 1 and Der f 1 belong to the papain family of cysteine proteases, and their amino acid sequences have 82% sequence similarity. However, their amino acid residues are unevenly distributed on the surface of the protein spatial structure, and their allergen epitopes do not completely overlap. How to specifically detect Der f 1 is a technical problem that needs to be solved urgently. Summary of the invention
[0005] In order to solve the above technical problems, the present invention provides a hybridoma cell for preparing a monoclonal antibody for detecting the main allergen Der f1 of dust mites and its application.
[0006] To achieve the above object, the present invention adopts the following technical solutions:
[0007] Hybridoma cells for preparing monoclonal antibodies for detecting dust mites and their main allergen Der f 1, the hybridoma cells were deposited on May 9, 2024 at the General Microbiology Center of China Culture Collection Administration (address: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, Postal Code 100101), and the deposit number is: CGMCC No.45854 and / or CGMCC No.45855.
[0008] The monoclonal antibody pair used to detect the content of dust mites and their major allergen Der f 1 was prepared by intraperitoneally injecting hybridoma cells with the deposit numbers of CGMCC No.45854 and CGMCC No.45855 into parous BALB / c female mice, collecting ascites and purifying antibodies to obtain anti-Der f 1 monoclonal antibodies DF1.10 and DF1.19.
[0009] The use of the monoclonal antibody against the major allergen Der f 1 of dust mites as described above in the preparation of an immune preparation for detecting dust mites and their major allergen Der f 1.
[0010] In the application as described above, preferably, the immune preparation is an EILSA detection reagent or an immunochromatographic detection reagent.
[0011] A method for detecting dust mites and their major allergen Der f 1, comprising the following steps:
[0012] S1. The antibody prepared by hybridoma cell CGMCC No.45854 is used as capture antibody to coat the ELISA coated plate;
[0013] S2, after washing, block with blocking solution and then wash;
[0014] S3, adding the test solution to the ELISA coated plate, incubating, and washing;
[0015] S4, adding HRP-conjugated antibodies prepared by hybridoma cell CGMCC No.45855, incubating, and washing;
[0016] S5. After adding TMB, add the stop solution to terminate the reaction and use an enzyme reader to detect the absorbance at a wavelength of 450nm.
[0017] In the above method, preferably, standard samples with different Der f 1 antigen protein concentrations are prepared at the same time. After detection according to the above method, a dose-response standard curve is drawn, and then the absorbance value of the test solution is substituted into the standard curve to obtain the concentration of Der f 1 antigen in the test solution.
[0018] The beneficial effects of the present invention are:
[0019] The present invention provides a hybridoma cell for preparing a monoclonal antibody for detecting dust mites and their major allergen Der f 1, which can be used to prepare an anti-Der f 1 monoclonal antibody, which can specifically recognize and bind to the Der f 1 protein, and has the advantages of high specificity and strong sensitivity. Under the same conditions, the anti-Der f 1 monoclonal antibody provided by the present invention is used to prepare an immunoassay reagent, which can accurately and specifically detect dust mites and their major allergen Der f 1. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 Schematic diagram of the dose-response standard curve.
[0021] Figure 2 It is the absorbance value for detecting the specific reaction to the main allergen of dust mites. DETAILED DESCRIPTION
[0022] The following examples are used to further illustrate the present invention, but should not be construed as limiting the present invention. Without departing from the spirit and substance of the present invention, modifications or substitutions made to the present invention all belong to the scope of the present invention.
[0023] Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art. Unless otherwise specified, all reagents used in the present method are of analytical grade or above.
[0024] Example 1 Immunization of BLAB / c mice
[0025] Take 40g of dust mite raw material (purchased from Beijing Xinhualian Xiehe Pharmaceutical Co., Ltd.), add 800ml NH 4 HCO 3 , extract overnight at 4°C. Centrifuge twice at 12,000g for 15min, take the supernatant, filter with filter paper, 0.22μm, about 600ml after filtration, slowly add 234g (NH 4 ) 2 SO 4, leave it to stand overnight at 4°C. Centrifuge twice at 12,000 g for 15 min, keep the supernatant, and dissolve the precipitate in 0.05 M Tris-HCl, pH 8.0 (about 37 ml). Dialyze overnight using 0.05 M Tris-HCl, pH 8.0. After dialysis, filter through a 0.22 μm PVDF membrane, and use a DEAE-cellulose anion exchange column: column equilibration (0.05 M Tris-HCl, PH 8.0), (elution) 500 ml of 0.05 M Tris-HCl containing 0.3 M NaCl, pH 7.4. Under this condition, the acidic protein Der f 1 (PI < pH, negatively charged) is eluted during the elution stage. Ultrafiltrate and concentrate to 40 mL, and dialyze into a buffer solution containing 0.05 M sodium borate and 2 M sodium chloride, pH 8.0. Continue to purify using a Phenyl column (equilibrated with 0.05 M sodium borate containing 2 M sodium chloride, pH 8.0), and then elute with a buffer solution containing 0.05 M sodium borate and 50% ethylene glycol, pH 8.0. Collect the eluate, ultrafiltrate and concentrate to 20 mL, then purify using a Superdex 75 column, collect the target peak, and ultrafiltrate and concentrate to 5 mL. Dialyze into 0.05 M Tris-acetate buffer (containing 0.5 M sodium chloride, pH 7.5), and then purify using a Zinc column (equilibrated with 0.05 M Tris-acetate buffer, pH 7.5, elute with a gradient decrease of 0.05 M Tris-acetate buffer, pH 7.5 - 5.0, and collect the peak eluted in the range of pH 5.7 - 5.2). Finally, obtain the purified Der f1 protein. Dialyze it into PBS for storage.
[0026] (II) Immunization of Mice
[0027] Take 5 healthy 6-week-old female BALB / c mice, fully mix 100 μL of 0.3 mg / mL Der f 1 protein (per mouse) with an equal volume of Freund's complete adjuvant, and inject subcutaneously at multiple points on the abdomen. The time interval between each immunization after the first immunization is two weeks. After the fifth immunization, collect blood from the orbital venous sinus one week later, collect the serum, and use the indirect ELISA method to determine the serum titer of the mice to evaluate the immune effect. If the O.D. at 450 nm is greater than 2.0 when the serum is diluted 1:4000, the serum titer is qualified. Three days before fusion, boost the immunization by injecting 100 μL of 0.3 mg / mL Der f 1 protein (per mouse) via the tail vein once.
[0028] Example 2 Preparation of Anti-Der f 1 Monoclonal Antibody
[0029] (I) Preparation of Myeloma Cells
[0030] One week before fusion, SP2 / 0 myeloma cells (purchased from the Cell Resource Center of the Institute of Basic Medicine, Chinese Academy of Medical Sciences) were revived and expanded to ensure that the cells were in the logarithmic growth phase and in the best condition at the time of fusion; on the day of fusion, the cells were gently blown off with a pipette, collected in a 50 mL centrifuge tube, centrifuged at 300 g for 5 min, the supernatant was discarded, and the cells were resuspended in IMDM medium and counted for later use.
[0031] (II) Preparation of feeder cells
[0032] Prepare feeder cells on the day of fusion as follows:
[0033] 1. Take a healthy female BALB / c mouse of 3 weeks old, remove the eyeball of the mouse and bleed it, and disinfect the body surface with 75% ethanol;
[0034] 2. Place the mouse on the operating table with the abdomen facing upward. Cut open the chest cavity below the sternum and you will see the white transparent thymus.
[0035] 3. Remove the thymus and soak it in IMDM medium;
[0036] 4. Place the thymus in a 200-mesh sieve and grind it gently with a tissue grinder until there are no obvious lumps;
[0037] 5. Rinse the sieve with 10 mL of IMDM medium and collect the rinse solution in a 15 mL centrifuge tube. Centrifuge at 300 g for 5 min and discard the supernatant.
[0038] 6. Resuspend the thymocytes with 10 mL of fetal bovine serum.
[0039] (III) Preparation of spleen cells from immunized mice
[0040] Prepare mouse spleen cells on the day of fusion as follows:
[0041] 1. Take a mouse immunized according to Example 1, remove its eyeballs and bleed it, and use 75% ethanol to disinfect its body surface;
[0042] 2. Place the mouse on the operating table with the left ventral side facing up; cut the skin in the middle of the left ventral side of the mouse, separate the skin and peritoneum, fully expose the abdominal wall, and the red long spleen can be seen;
[0043] 3. Lift the peritoneum on the lower side of the spleen, cut it open and flip it up to expose the spleen, lift the spleen with forceps, separate the connective tissue under the spleen with scissors, and take out the spleen; put it into a sterile EP tube containing 5 mL of IMDM culture medium;
[0044] 4. Place the spleen in a 200-mesh sieve and grind it gently with a tissue grinder until there are no obvious lumps;
[0045] 5. Rinse the sieve with 10 mL of IMDM medium and collect the rinse solution in a 15 mL centrifuge tube. Centrifuge at 300 g for 5 min and discard the supernatant.
[0046] 6. Resuspend mouse spleen cells in IMDM.
[0047] (IV) Cell fusion
[0048] 1. Take 1×10 8 splenocytes of immunized mice and 1×10 7 Add SP2 / 0 myeloma cells to a 50 mL centrifuge tube, add IMDM to a final volume of 10 mL, and centrifuge at 300 g for 5 min;
[0049] 2. Discard the supernatant and remove the remaining liquid as much as possible. Tap the bottom of the fusion tube lightly with your palm to loosen and evenly distribute the precipitated cells.
[0050] 3. Place the centrifuge tube in 37℃ sterile water, slowly add 1mL 50% PEG 1500 fusion agent into the centrifuge tube, add it within about 1 minute, and let it stand for 1 minute;
[0051] 4. Slowly add 2 mL of IMDM medium along the wall of the centrifuge tube for about 2 minutes.
[0052] 5. Then, within 2 minutes, 8 mL of IMDM medium was slowly added to terminate the action of PEG 1500 fusion agent and obtain fused cells;
[0053] 6. Centrifuge the fused cells at 300g for 5 minutes, discard the supernatant, mix the precipitate with thymocytes, add 2mL of HAT selection medium, and add IMDM medium to make the final volume 15mL;
[0054] 7. Pour 25 mL of 2% methylcellulose IMDM semi-solid medium and mix thoroughly. Inoculate into a 35 mm diameter sterile plastic dish, 2 mL / dish. Place the plastic dish in a humidified chamber at 37°C and 5% CO. 2 Culture in an incubator.
[0055] (V) Clonal transfer
[0056] On the sixth day after fusion, a healthy female BALB / c mouse aged 3 weeks was taken and feeder cells were prepared according to 1-5 of (II). An appropriate amount of DMEM medium containing 20% fetal bovine serum was added to the precipitated thymocytes to make the cell density 10 5 Under a dissecting microscope, use a pipette to transfer the clones in the dish to a 96-well plate for further culture.
[0057] (VI) Screening of hybridoma cells
[0058] Two days after the clone transfer, the positive clones were screened by indirect enzyme-linked immunosorbent assay. The purified natural Der f 1 protein was coated and prepared into 2.5 μg / ml, and added at 100 μl / well, and incubated at 4°C overnight; blocked at room temperature (TBST containing 0.5% BSA) for 2 hours; 100 μL of the cell culture supernatant of the 96-well plate in Example 2 (V) was added to each well, and 100 μL of the immune mouse serum (1:100 dilution) in Example 2 (III) was added to the positive control well, and 100 μL of the healthy mouse serum (1:100 dilution) in Example 2 (II) was added to the negative control well, and incubated at 37°C for 30 minutes; after washing, peroxidase-labeled goat anti-mouse IgG secondary antibody (1:5000) was added, 100 μL / well, and incubated at 37°C for 30 minutes; after washing, substrate solution (TMB) was added, 100 μL / well, and color was developed in the dark for 10 minutes; 50 μL 2M H 2 SO 4 The reaction was terminated, and the absorbance at a wavelength of 450 nm was detected using an enzyme reader. If the OD value of the measured well / OD value of the negative control well (S / N) was greater than 2.1, it was judged as positive, and the positive clones with OD values greater than 1.0 were retained.
[0059] The positive clones screened out were retested the next day, and the recombinant His-alt a 1 protein was used as an antigen to exclude clones targeting the His tag. A total of 4 positive hybridoma cell lines were screened out, named DF1.10, DF1.19, DF1.24, and DF1.26, which were expanded and cultured in time and frozen in liquid nitrogen.
[0060] (VII) Large-scale preparation of monoclonal antibodies
[0061] Ascites was prepared using the in vivo ascites induction method. The specific steps are as follows:
[0062] 1. Select multiparous female BLAB / c mice and intraperitoneally inject 0.5 mL of sterilized liquid paraffin oil per mouse;
[0063] 2. Resuscitate the above 4 frozen hybridoma cells and continue to culture. Select the hybridoma cells in the logarithmic growth phase, blow them off gently, centrifuge them at 300g for 5 minutes, discard the supernatant, resuspend them with DMEM, count them and set aside;
[0064] 3. Each mouse was intraperitoneally injected with 5×10 5 -1×10 6 hybridoma cells;
[0065] 4. After 7-10 days, the abdomen of the mouse will be significantly enlarged, and ascites will be collected;
[0066] 5. Centrifuge the mouse ascites at 3000 rpm for 10 min, collect the supernatant, and store it at -20°C for later use.
[0067] (VIII) Purification of Ascites
[0068] 1. Dilute the ascites with 4 volumes of acetate buffer (60 mM pH 4.0, pH 4.5);
[0069] 2. Add 25 μl of octanoic acid per ml of diluted sample, stirring for 30 min, and centrifuge at 10,000 g at 16°C for 30 min.
[0070] 3. Filter the supernatant with filter paper to remove fine residues, add 10-fold concentrated PBS (9 samples plus 1 part PBS), and adjust the pH to 7.4 with 5NNaOH;
[0071] 4. Cool the supernatant to 4°C, add 45% saturated ammonium sulfate to precipitate the supernatant (0.277 g / mL), and let stand at 4°C for 30 min;
[0072] 5. Centrifuge at 10,000 g for 10 min at 4°C. Resuspend the precipitate in a small amount of PBS and dialyze against PBS at 4°C overnight to obtain four purified antibody solutions, corresponding to the monoclonal purified antibodies DF1.10, DF1.19, DF1.24, and DF1.26.
[0073] Example 3 Identification and pairing of anti-Der f 1 monoclonal antibodies
[0074] (I) Pairing test
[0075] Take 5 mg of horseradish peroxidase (HRP), dissolve it in 0.5 mL of 0.2 M sodium acetate buffer (pH 5.6), mix it with 0.25 mL of 0.1 M sodium periodate solution, and place it at 4 ° C for 30 min. Add 0.5 mL of 2.5% ethylene glycol solution, mix it and place it in a 4 ° C refrigerator for 30 min. Take the purified antibodies (DF1.10, DF1.19, DF1.24, DF1.26) obtained in Example 2 and prepare them into 5 mg / mL 1 mL respectively, and adjust the pH to 9.0 with 1 M sodium carbonate buffer (pH 9.5). Mix the purified antibody solution and HRP solution, adjust the pH to 9.0 with 1 M sodium carbonate buffer (pH 9.5), and place it in a 4 ° C refrigerator overnight. Add 0.1 mL of 0.1 M sodium borohydride solution, place it at 4 ° C for 2 h to terminate the reaction, and obtain HRP-conjugated antibodies. The HRP-conjugated antibody was added to a dialysis bag, placed in a 0.01 M PBS solution (pH 7.4), and dialyzed overnight at 4° C. The HRP-conjugated antibody was collected, added with 0.5% BSA, and stored in a 4° C. refrigerator.
[0076] The double antibody sandwich method was used for antibody cross-pairing, with unlabeled purified antibodies as capture antibodies, Der p 1 and Der f 1 antigens (purchased from Indoor Biotechnologies) as samples, and HRP-conjugated antibodies as detection antibodies, to screen out a series of specific antibody pairs that can be paired and do not react with Der p 1.
[0077] The experimental operation is as follows:
[0078] 1. Take capture antibodies (DF1.10, DF1.19, DF1.24, DF1.26) and add them to coating buffer (0.05M Tris-HCl) to a final concentration of 3.5μg / mL. Add 100μL to each well and incubate at 4℃ overnight.
[0079] 2. Take out and wash three times with 300 μL TBST per well.
[0080] 3. Add 200 μL of blocking solution (TBST containing 0.5% BSA) to each well and leave at room temperature for 2 h.
[0081] 4. Discard the blocking solution and make a DF1 capture coated plate after drying.
[0082] 5. Take 50 ng / mL of Der p 1 and Der f 1 antigens, 100 μL / well, and add them into the wells of the coated plate configured above;
[0083] 6. Cover with sealing film and incubate at 37°C for 30 minutes;
[0084] 7. Take out, wash the plate 3 times with washing solution (TBST), and pat dry;
[0085] 8. Dilute the HRP-conjugated antibody prepared above with 1:4000 blocking solution, 100 μL / well, and add to the wells of the coated plate prepared above;
[0086] 9. Cover with sealing film and incubate at 37°C for 30 minutes;
[0087] 10. Take out, wash the plate 3 times with washing solution (TBST), and pat dry;
[0088] 11. Add 100 μL TMB to each well and react for 10 minutes;
[0089] 12. Add 50 μL stop solution (2M H 2 SO 4 ) terminate the reaction;
[0090] 13. Use an enzyme-labeled instrument to detect the absorbance value at a wavelength of 450 nm. The results are shown in Table 1.
[0091] Table 1
[0092]
[0093] The meaning of OVRFLW in the table is that the value is too high and has exceeded the detection limit of the instrument. The results show that the DF1.10-DF1.19-HRP group has the highest absorbance value and a lower detection value for Der p 1, indicating that there is no cross-reaction with the Der p 1 antigen, indicating that the antibodies of these two strains have the strongest ability to specifically bind to the Der f 1 antigen. This pair of antibodies was selected for antibody type identification, titer determination, and cross-reactivity determination.
[0094] The obtained hybridoma cells DF1.10 and DF1.19 were sent to the General Microbiology Center of China Culture Collection Administration (address: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, Postal Code: 100101) for patent preservation on May 9, 2024, and their preservation numbers are: CGMCC No.45854 and CGMCC No.45855, respectively, and they are classified and named as mouse hybridoma cells.
[0095] (II) Identification of antibody types
[0096] Agar was prepared into 100 mL of 2% agarose solution with a pH 6.0 barbiturate buffer and boiled in water. When the temperature of the molten agar was about 50°C, 0.01 g of sodium azide was added, and 16 mL of agarose solution was moved to a transparent pre-coated glass plate (10×8.5 cm) to make an agar plate. After the agar solidified, a central hole and six peripheral holes were punched in the agar, and the agar in the holes was removed with a needle. The antibodies DF1.10 and DF1.19 prepared by the present invention were placed in the central hole, and IgG1, IgG2a, and IgG2b (purchased from Southern Biotech) solutions were placed in the peripheral holes. The agar plate with the sample added was placed in a wet box and placed in a 37°C incubator for 24 hours to observe the results. The precipitation line formed between the central hole and the IgG1 hole indicated that the antibody DF1.10 and DF1.19 cell line subtype prepared by the present invention was IgG1.
[0097] Example 4 Application of Antibody Pairs in ELISA Kits
[0098] According to the existing chemiluminescence diagnostic reagent production process, the monoclonal antibody DF1.10 obtained in Example 2 was used as a capture antibody to be coated and configured into a Der f 1 coated plate, the monoclonal antibody DF1.19-HRP obtained in Example 2 was used as a binding antibody to be configured into a Der f 1 enzyme conjugate, and the Der f 1 antigen obtained in Example 1 was configured into a series of calibrators (0.5 ng / ml, 1 ng / ml, 2 ng / ml, 4 ng / ml, 8 ng / ml, 16 ng / ml, 32 ng / ml) to form a complete kit, and a series of verifications were performed on it.
[0099] (I) Performance verification indicators
[0100] Refer to the technical requirements of the existing Der f 1 detection kits on the market and formulate performance verification indicators for the detection reagents.
[0101] 1. Linearity of dose-response curve
[0102] In the linear range of 0.5ng / mL-32ng / mL, the linear correlation coefficient (r) of the dose-response curve should be no less than 0.9900.
[0103] 2. Detection limit
[0104] Should not be higher than 1ng / mL.
[0105] 3. Limit of Quantitation
[0106] Should not be higher than 2ng / mL.
[0107] 4. Specificity
[0108] The established method was used to detect the concentrations of serially diluted Der p1, Der p2, Der f1, and Der f2 to verify the specificity of the method.
[0109] 5. Accuracy
[0110] The recovery rate of spiked samples was tested with a test kit and the result should be within the range of 80%-120%.
[0111] 6. Precision
[0112] The precision (CV) should not be greater than 15%.
[0113] (II) Experimental configuration
[0114] 1. DF 1.10 capture antibody coated plate configuration
[0115] Use monoclonal antibody DF 1.10 as capture antibody, add coating buffer (0.05M Tris-HCl) to a final concentration of 3.5μg / mL. Add 100μL to each well and incubate at 4℃ overnight. Remove and discard the supernatant, wash 3 times with 300μL TBST per well. Add 200μL blocking solution (TBST solution containing 0.5% BSA) to each well and leave at room temperature for 2h. Discard the blocking solution and make a DF1.10 capture coating plate after drying.
[0116] 2. DF 1.19 enzyme conjugate configuration
[0117] The monoclonal antibody DF1.19-HRP conjugated antibody obtained in Example 3 was added to the enzyme diluent (0.1 M Tris solution containing 0.5% BSA) at a ratio of 1:4000.
[0118] 3. Calibration product configuration
[0119] The Der f 1 antigen was diluted with an antigen diluent (0.5% BSA-PBS) into seven gradients (0.5 ng / mL, 1 ng / mL, 2 ng / mL, 4 ng / mL, 8 ng / mL, 16 ng / mL, and 32 ng / mL).
[0120] 4. Recovery rate standard solution configuration
[0121] The Der f 1 antigen was diluted with an antigen diluent (PBS solution containing 0.5% BSA) as a standard solution, and 1.92 ng / mL dust mite extract (Beijing Union New Hualian Pharmaceutical Co., Ltd.) was selected as a low-value sample.
[0122] 5. Quality control product configuration
[0123] Der f 1 antigen was diluted with antigen diluent (PBS solution containing 0.5% BSA) to form QC1 (2 ng / mL±10%), QC2 (6 ng / mL±10%) and QC3 (20 ng / mL±10%).
[0124] (III) Sample addition operation
[0125] 1. Take 100 μL of the above-prepared calibrator, recovery sample and quality control sample respectively and add them into the wells of the above-prepared coated plate;
[0126] 2. Cover with sealing film and incubate at 37℃ for 30 minutes;
[0127] 3. Take out, wash the plate 3 times with washing solution (TBST), and pat dry;
[0128] 4. Take 100 μL of the above-prepared DF1.19-HRP conjugated antibody and add it into the wells of the above-prepared coated plate;
[0129] 5. Cover with sealing film and incubate at 37℃ for 30 minutes;
[0130] 6. Take out, wash the plate 3 times with washing solution (TBST), and pat dry;
[0131] 7. Add 100 μL TMB to each well and react for 10 minutes;
[0132] 8. Add 50 μL of stop solution (2M H 2 SO 4 ) terminate the reaction;
[0133] 9. Use an ELISA reader to detect the absorbance value at a wavelength of 450nm.
[0134] (IV) Performance Index Assessment
[0135] 1. Linearity of dose-response curve
[0136] The calibrators of the duplicate assay kit (concentrations were 0.5 ng / mL, 1 ng / mL, 2 ng / mL, 4 ng / mL, 8 ng / mL, 16 ng / mL, and 32 ng / mL, respectively) were measured three times in parallel, and the dose-response curve of the kit was fitted by the least squares method. The dose-response curve is shown in Figure 1 shown.
[0137] Depend on Figure 1 It can be seen that the linear correlation coefficient R of the Der f 1 antigen curve in the concentration range of 0.5-32ng / ml 2 Greater than 0.9990, meeting the specifications.
[0138] 2. Detection limit
[0139] Using sample diluent (0.5% BSA-PBS) as the sample, repeat the measurement 20 times, obtain the OD450 value of the 20 measurement results, calculate the mean (M) and standard deviation (SD), obtain the A450 value corresponding to M+2SD, substitute it into the standard curve equation of the standard substance, and find the corresponding concentration value, which is the detection limit. The results are shown in Table 2, and the detection limit is 0.22ng / mL.
[0140] Table 2
[0141]
[0142] 3. Limit of Quantitation
[0143] After the standard was diluted to 0.25, 0.5, and 1 ng / mL, the determination was repeated 10 times, and the average and SD of the 10 determination results were calculated to obtain the coefficient of variation (CV). The lowest concentration with CV ≤ 15% was selected as the limit of quantification. The results are shown in Table 3, and the limit of quantification was 0.5 ng / mL.
[0144] Table 3
[0145]
[0146]
[0147] 4. Specificity
[0148] The established method was used to detect a variety of dust mite allergens. Except for Der f 1, the OD 450 values of different concentrations of Der f 2, Der p1, and Der p2 (purchased from Indoor Biotechnologies) were all lower than the blank, indicating that the method has good specificity. Figure 2 shown.
[0149] 5. Accuracy
[0150] The Der f 1 antigen was prepared into a standard solution (130, 10 ng / mL) and added to the low-value sample of known concentration at a volume ratio of 1:9. The test was repeated 3 times using the kit, and the recovery rate R was calculated according to the formula below. The results are shown in Table 4.
[0151]
[0152] Where:
[0153] R—Recovery rate
[0154] V—Volume of standard solution added
[0155] V 0 —Low sample volume
[0156] C—Measured concentration of sample after spike
[0157] C 0 — Low sample concentration
[0158] C S —Concentration of standard solution
[0159] Table 4
[0160] Standard solution concentration (ng / mL) Low value sample concentration (ng / mL) Detection value (ng / mL) Recovery rate L1 130 1.92 15.72 107.63% L2 10 1.92 2.79 106.20%
[0161] 6. Precision
[0162] Ten wells of each of the quality control products Q1, Q2 and Q3 were measured in parallel, and the CV was calculated. The results are shown in Table 5.
[0163] Table 5
[0164] M (ng / mL) SD CV Q1 1.91 0.16 8.38% Q2 5.86 0.51 8.70% Q3 20.63 0.84 4.07%
[0165] The results show that the monoclonal antibody prepared by the present invention has good specificity and can be used as a coating antibody for ELISA and western blot to detect Der F1 antigen.
[0166] Comparative Example
[0167] Der f 1 was detected by double antibody sandwich method using the existing Der f 1 detection kit (Indoor Biotechnologies) on the market, and the total incubation time of the sample and the detection antibody was 2 hours.
[0168] It can be seen that in the kit for detecting Der f 1 provided by the present invention, the total incubation time of the sample and the detection antibody is 1 hour, which requires a shorter reaction time and is more rapid.
Claims
1. A mouse hybridoma cell, characterized in that: Its deposit number is: CGMCC No.45844 or CGMCC No.45855.
2. A hybridoma cell for preparing a monoclonal antibody for detecting dust mites and its major allergen Der f 1, characterized in that: The hybridoma cells were deposited in the General Microbiology Center of China Microorganism Culture Collection Administration on May 9, 2024, with the deposit numbers: CGMCC No.45854 and / or CGMCCNo.45855.
3. A monoclonal antibody pair for detecting the content of dust mites and their major allergen Der f 1, characterized in that: The method comprises injecting hybridoma cells with the deposit numbers of CGMCC No. 45854 and CGMCC No. 45855 into parous BALB / c female mice intraperitoneally, collecting ascites, and purifying antibodies to obtain anti-Der f 1 monoclonal antibodies DF1.10 and DF1.
19.
4. Use of the antibody pair for detecting the content of dust mites and their major allergen Der f 1 as claimed in claim 3 in the preparation of an immune preparation for detecting dust mites and their major allergen Der f 1.
5. The use according to claim 4, characterized in that The immune preparation is an EILSA detection reagent or an immunochromatographic detection reagent.
6. A detection kit for detecting dust mites and their major allergen Der f 1, comprising a monoclonal antibody prepared by mouse hybridoma cells with a deposit number of CGMCC No. 45854 as a capture antibody, and a monoclonal antibody labeled with HRP prepared by mouse hybridoma cells with a deposit number of CGMCC No. 45855 as a detection antibody.
7. A method for detecting dust mites and their major allergen Der f 1, characterized in that: It includes the following steps: S1. The antibody prepared by hybridoma cell CGMCC No.45854 is used as capture antibody to coat the ELISA coated plate; S2, after washing, block with blocking solution and then wash; S3, adding the test solution to the ELISA coated plate, incubating, and washing; S4, adding HRP-conjugated antibodies prepared by hybridoma cell CGMCC No.45855, incubating, and washing; S5. After adding TMB, add the stop solution to terminate the reaction and use an enzyme reader to detect the absorbance at a wavelength of 450nm.
8. The method according to claim 7, characterized in that At the same time, standard samples with different Der f 1 antigen protein concentrations were prepared. After detection according to the above method, a dose-response standard curve was drawn. Then, the absorbance value of the test solution was substituted into the standard curve to obtain the concentration of Der f 1 antigen in the test solution.
